Free Trial

Tourmaline Bio (TRML) SEC Filings & 10K Form

$13.45
-0.21 (-1.54%)
(As of 05/24/2024 ET)

Recent Tourmaline Bio SEC Filings

DateFilerForm TypeView
05/13/2024
6:15 AM
Tourmaline Bio, Inc. (Filer)
Tourmaline Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/19/2024
6:09 AM
Tourmaline Bio, Inc. (Filer)
Tourmaline Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/15/2024
6:45 AM
PFIZER INC (Filed by)
Tourmaline Bio, Inc. (Subject)
Tourmaline Bio (Subject)
Form SC 13G/A
02/14/2024
8:08 PM
Hydra LLC (Filed by)
Tourmaline Bio, Inc. (Subject)
Tourmaline Bio (Subject)
Form SC 13G/A
02/14/2024
7:51 PM
Blue Owl Capital Holdings LP (Filed by)
Tourmaline Bio, Inc. (Subject)
Tourmaline Bio (Subject)
Form SC 13G
02/14/2024
3:57 PM
CITADEL ADVISORS LLC (Filed by)
Tourmaline Bio, Inc. (Subject)
Tourmaline Bio (Subject)
Form SC 13G/A
02/09/2024
4:24 PM
Blackstone Holdings II L.P. (Filed by)
Tourmaline Bio, Inc. (Subject)
Tourmaline Bio (Subject)
Form SC 13G/A
02/07/2024
1:11 PM
BML Investment Partners, L.P. (Filed by)
Tourmaline Bio, Inc. (Subject)
Tourmaline Bio (Subject)
Form SC 13G/A
01/31/2024
3:26 PM
MCDADE MARK (Reporting)
Tourmaline Bio, Inc. (Issuer)
Tourmaline Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2024
8:20 PM
Tourmaline Bio, Inc. (Filer)
Tourmaline Bio (Filer)
Form 424B5
01/08/2024
8:19 AM
Tourmaline Bio, Inc. (Filer)
Tourmaline Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/14/2023
7:27 AM
Tourmaline Bio, Inc. (Filer)
Tourmaline Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/30/2023
7:25 AM
Tourmaline Bio, Inc. (Filer)
Tourmaline Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/20/2023
5:14 PM
Thiara Parvinder (Reporting)
Tourmaline Bio, Inc. (Issuer)
Tourmaline Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2023
5:15 PM
Kulkarni Sandeep Chidambar (Reporting)
Tourmaline Bio, Inc. (Issuer)
Tourmaline Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2023
3:30 PM
Hydra LLC (Filed by)
Tourmaline Bio, Inc. (Subject)
Tourmaline Bio (Subject)
Form SC 13G
10/30/2023
4:16 PM
Longitude Capital Partners III, LLC (Filed by)
Tourmaline Bio, Inc. (Subject)
Tourmaline Bio (Subject)
Form SC 13D/A
10/30/2023
3:15 PM
Qiming U.S. Healthcare GP II, LLC (Filed by)
Tourmaline Bio, Inc. (Subject)
Tourmaline Bio (Subject)
Form SC 13D/A
10/27/2023
4:43 PM
Castelein Caley (Reporting)
Tourmaline Bio, Inc. (Issuer)
Tourmaline Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/27/2023
4:17 PM
Tourmaline Bio, Inc. (Filer)
Tourmaline Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/26/2023
4:00 PM
KANTOFF AARON (Reporting)
Tourmaline Bio, Inc. (Issuer)
Tourmaline Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/26/2023
4:34 PM
Kulkarni Sandeep Chidambar (Reporting)
Tourmaline Bio, Inc. (Issuer)
Tourmaline Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/26/2023
3:46 PM
Thiara Parvinder (Reporting)
Tourmaline Bio, Inc. (Issuer)
Tourmaline Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/23/2023
7:25 PM
Kulkarni Sandeep Chidambar (Reporting)
Tourmaline Bio, Inc. (Issuer)
Tourmaline Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/23/2023
7:26 PM
MCDADE MARK (Reporting)
Tourmaline Bio, Inc. (Issuer)
Tourmaline Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/23/2023
7:29 PM
MIDDLEKAUFF W BRADFORD (Reporting)
Tourmaline Bio, Inc. (Issuer)
Tourmaline Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/23/2023
7:30 PM
Robinson Ryan F. (Reporting)
Tourmaline Bio, Inc. (Issuer)
Tourmaline Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/23/2023
7:31 PM
Srivastava Sapna (Reporting)
Tourmaline Bio, Inc. (Issuer)
Tourmaline Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/23/2023
7:33 PM
Thiara Parvinder (Reporting)
Tourmaline Bio, Inc. (Issuer)
Tourmaline Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/23/2023
7:18 PM
Castelein Caley (Reporting)
Tourmaline Bio, Inc. (Issuer)
Tourmaline Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/23/2023
7:20 PM
CHYUNG YUNG H. (Reporting)
Tourmaline Bio, Inc. (Issuer)
Tourmaline Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/23/2023
7:21 PM
Johnson Kevin Bruce (Reporting)
Tourmaline Bio, Inc. (Issuer)
Tourmaline Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/23/2023
7:23 PM
Jones Susan Dana (Reporting)
Tourmaline Bio, Inc. (Issuer)
Tourmaline Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/23/2023
7:24 PM
KANTOFF AARON (Reporting)
Tourmaline Bio, Inc. (Issuer)
Tourmaline Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/23/2023
5:27 PM
Castelein Caley (Reporting)
Tourmaline Bio, Inc. (Issuer)
Tourmaline Bio (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/23/2023
5:27 PM
Chester Cariad (Reporting)
Tourmaline Bio, Inc. (Issuer)
Tourmaline Bio (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/23/2023
5:28 PM
CHYUNG YUNG H. (Reporting)
Tourmaline Bio, Inc. (Issuer)
Tourmaline Bio (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/23/2023
5:29 PM
Johnson Kevin Bruce (Reporting)
Tourmaline Bio, Inc. (Issuer)
Tourmaline Bio (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/23/2023
5:30 PM
Jones Susan Dana (Reporting)
Tourmaline Bio, Inc. (Issuer)
Tourmaline Bio (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/23/2023
5:31 PM
KANTOFF AARON (Reporting)
Tourmaline Bio, Inc. (Issuer)
Tourmaline Bio (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/23/2023
5:31 PM
Kulkarni Sandeep Chidambar (Reporting)
Tourmaline Bio, Inc. (Issuer)
Tourmaline Bio (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
Protect Your Bank Account Before It’s Too Late (Ad)

For months I’ve been warning about the federal government’s terrifying new program to control every American’s bank account. It gives them the power to monitor every single transaction …

Stop right now and do these 3 things to protect yourself
10/23/2023
5:32 PM
MIDDLEKAUFF W BRADFORD (Reporting)
Tourmaline Bio, Inc. (Issuer)
Tourmaline Bio (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/23/2023
5:33 PM
Robinson Ryan F. (Reporting)
Tourmaline Bio, Inc. (Issuer)
Tourmaline Bio (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/23/2023
5:34 PM
Thiara Parvinder (Reporting)
Tourmaline Bio, Inc. (Issuer)
Tourmaline Bio (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/20/2023
8:23 PM
Tourmaline Bio, Inc. (Filer)
Tourmaline Bio (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
10/19/2023
8:11 PM
Tourmaline Bio, Inc. (Filer)
Tourmaline Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/10/2023
3:32 PM
Talaris Therapeutics, Inc. (Subject)
Tourmaline Bio (Subject)
Form 425
10/10/2023
3:30 PM
Talaris Therapeutics, Inc. (Filer)
Tourmaline Bio (Filer)
Form 8-K/A
10/06/2023
4:26 PM
Talaris Therapeutics, Inc. (Filer)
Tourmaline Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/06/2023
4:27 PM
Talaris Therapeutics, Inc. (Subject)
Tourmaline Bio (Subject)
Form 425
10/06/2023
4:30 PM
Talaris Therapeutics, Inc. (Filer)
Tourmaline Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/26/2023
7:21 AM
Talaris Therapeutics, Inc. (Filer)
Tourmaline Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/26/2023
7:24 AM
Talaris Therapeutics, Inc. (Subject)
Tourmaline Bio (Subject)
Form 425
09/15/2023
5:31 AM
Talaris Therapeutics, Inc. (Filer)
Tourmaline Bio (Filer)
Form 424B3
09/14/2023
11:15 PM
Talaris Therapeutics, Inc. (Filer)
Tourmaline Bio (Filer)
Form EFFECT
09/13/2023
3:28 PM
Talaris Therapeutics, Inc. (Filer)
Tourmaline Bio (Filer)
Form S-4/A
09/13/2023
8:13 AM
Talaris Therapeutics, Inc. (Filer)
Tourmaline Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/13/2023
8:14 AM
Talaris Therapeutics, Inc. (Subject)
Tourmaline Bio (Subject)
Form 425
09/11/2023
3:47 PM
Talaris Therapeutics, Inc. (Filer)
Tourmaline Bio (Filer)
Form S-4/A
08/28/2023
6:38 AM
Talaris Therapeutics, Inc. (Subject)
Tourmaline Bio (Subject)
Form 425
08/25/2023
3:34 PM
Talaris Therapeutics, Inc. (Filer)
Tourmaline Bio (Filer)
Form S-4/A
08/14/2023
6:53 AM
Talaris Therapeutics, Inc. (Filer)
Tourmaline Bio (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/19/2023
6:57 PM
Talaris Therapeutics, Inc. (Filer)
Tourmaline Bio (Filer)
Form S-4
Registration statement under Securities Act of 1933  
07/06/2023
4:19 PM
Requadt Scott (Reporting)
Talaris Therapeutics, Inc. (Issuer)
Tourmaline Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/06/2023
4:20 PM
Fenton Mary Kay (Reporting)
Talaris Therapeutics, Inc. (Issuer)
Tourmaline Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/06/2023
3:32 PM
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Talaris Therapeutics, Inc. (Subject)
Tourmaline Bio (Subject)
Form SC 13G
07/05/2023
4:10 PM
Requadt Scott (Reporting)
Talaris Therapeutics, Inc. (Subject)
Tourmaline Bio (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/05/2023
3:52 PM
Fenton Mary Kay (Reporting)
Talaris Therapeutics, Inc. (Subject)
Tourmaline Bio (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/22/2023
8:10 AM
Talaris Therapeutics, Inc. (Filer)
Tourmaline Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/22/2023
8:12 AM
Talaris Therapeutics, Inc. (Subject)
Tourmaline Bio (Subject)
Form 425
06/14/2023
5:56 PM
Agarwala Sandip (Reporting)
Talaris Therapeutics, Inc. (Issuer)
Tourmaline Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2023
5:58 PM
Ildstad Suzanne (Reporting)
Talaris Therapeutics, Inc. (Issuer)
Tourmaline Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2023
5:59 PM
MACKAY GEOFFREY (Reporting)
Talaris Therapeutics, Inc. (Issuer)
Tourmaline Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2023
5:59 PM
MCDADE MARK (Reporting)
Talaris Therapeutics, Inc. (Issuer)
Tourmaline Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2023
6:00 PM
Nader Francois (Reporting)
Talaris Therapeutics, Inc. (Issuer)
Tourmaline Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2023
6:01 PM
Shah Gaurav (Reporting)
Talaris Therapeutics, Inc. (Issuer)
Tourmaline Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2023
6:02 PM
Smith Karen L. (Reporting)
Talaris Therapeutics, Inc. (Issuer)
Tourmaline Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2023
6:03 PM
Srivastava Sapna (Reporting)
Talaris Therapeutics, Inc. (Issuer)
Tourmaline Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2023
4:41 PM
Ildstad Suzanne (Reporting)
Talaris Therapeutics, Inc. (Issuer)
Tourmaline Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2023
5:24 PM
Ildstad Suzanne (Reporting)
Talaris Therapeutics, Inc. (Issuer)
Tourmaline Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/01/2023
3:21 PM
Ildstad Suzanne (Reporting)
Talaris Therapeutics, Inc. (Subject)
Tourmaline Bio (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:TRML) was last updated on 5/24/2024 by MarketBeat.com Staff

From Our Partners